Comerica Bank Increases Stock Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Comerica Bank raised its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 71.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,462 shares of the company’s stock after acquiring an additional 610 shares during the period. Comerica Bank’s holdings in iShares U.S. Pharmaceuticals ETF were worth $99,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Kraft Davis & Associates LLC grew its position in shares of iShares U.S. Pharmaceuticals ETF by 116.8% during the first quarter. Kraft Davis & Associates LLC now owns 24,294 shares of the company’s stock worth $1,590,000 after acquiring an additional 13,088 shares during the last quarter. Axxcess Wealth Management LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 201.3% in the first quarter. Axxcess Wealth Management LLC now owns 3,362 shares of the company’s stock valued at $228,000 after buying an additional 2,246 shares during the last quarter. Patten & Patten Inc. TN boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 194.5% during the first quarter. Patten & Patten Inc. TN now owns 16,932 shares of the company’s stock worth $1,150,000 after buying an additional 11,183 shares during the period. Texas Yale Capital Corp. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 179.2% during the first quarter. Texas Yale Capital Corp. now owns 13,430 shares of the company’s stock worth $912,000 after buying an additional 8,620 shares during the last quarter. Finally, Oppenheimer & Co. Inc. increased its position in iShares U.S. Pharmaceuticals ETF by 200.0% in the 1st quarter. Oppenheimer & Co. Inc. now owns 6,786 shares of the company’s stock valued at $461,000 after acquiring an additional 4,524 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Down 0.2 %

iShares U.S. Pharmaceuticals ETF stock opened at $70.07 on Monday. The stock has a 50 day moving average of $67.63 and a two-hundred day moving average of $66.71. iShares U.S. Pharmaceuticals ETF has a twelve month low of $55.36 and a twelve month high of $70.33. The stock has a market capitalization of $707.71 million, a price-to-earnings ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.